![](/img/cover-not-exists.png)
351PImpact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: Results from the AGMT_MBC-registry
Gampenrieder, S P P, Rinnerthaler, G, Petzer, A, Tinchon, C, Fuchs, D, Balic, M, Heibl, S, Rumpold, H, Egle, D, Zabernigg, A F, Singer, C F, Andel, J, Hubalek, M, Knauer, M, Greil, RVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.046
Date:
October, 2019
File:
PDF, 86 KB
2019